Cymabay Therapeutics Inc (CBAY.OQ)
CBAY.OQ on NASDAQ Stock Exchange Global Select Market
10.18USD
21 Feb 2019
10.18USD
21 Feb 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$10.18
$10.18
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
193,443
193,443
52-wk High
$15.59
$15.59
52-wk Low
$6.33
$6.33
About
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)
Overall
| Beta: | 2.08 |
| Market Cap(Mil.): | $358.81 |
| Shares Outstanding(Mil.): | 43.76 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBAY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -1.06 | -- | -- |
| ROI: | -182.71 | 8.92 | 14.45 |
| ROE: | -308.78 | 10.08 | 15.96 |
Estimates